TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Med-El has launched the TICI Unico, which the company describes as the world’s only totally invisible cochlear implant, with all components — including the microphone — implanted under the skin. The launch follows feasibility study results and early surgeries in Europe, and targets users who want discretion and round-the-clock hearing.
Med-El has officially launched the TICI Unico, a cochlear implant the company describes as the world’s only totally invisible cochlear implant, with every component — including the microphone — implanted completely beneath the skin. The announcement, reported by The Hearing Review, marks the commercial arrival of fully implantable cochlear implant technology after years of development and early surgeries in Europe. The device eliminates the external sound processor that conventional cochlear implants require, addressing a longstanding goal in the field: hearing restoration through a device imperceptible to others.
The TICI Unico is designed to function entirely subcutaneously, with no external hardware required during everyday use, according to Med-El. Unlike conventional cochlear implants, which rely on an external sound processor worn behind the ear or on the head, the TICI Unico’s microphone and electronics are housed under the skin. Because nothing sits outside the body, Med-El says the implant works 24/7 — including while sleeping, showering, and swimming — and is not affected by water.
The launch is the commercial product of a development program that has been closely tracked by the hearing healthcare industry over several years. Med-El previously reported promising feasibility study results for its TICI platform and conducted early surgeries with the technology in Europe, according to The Hearing Review. The TICI Unico is positioned for patients who prioritize discretion and convenience alongside hearing performance.
The announcement comes during a period of notable activity for the Innsbruck, Austria-based manufacturer. Med-El recently acquired two gene therapy programs from Rescue Hearing and expanded its device connectivity portfolio through a collaboration with Starkey on bimodal Bluetooth. The company is privately held and develops cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants.
The launch matters because device visibility has long been a barrier to cochlear implant adoption. Med-El CEO Ingeborg Hochmair said she hopes the device will “open the door to hearing for many more people than currently are interested in cochlear implants,” pointing to stigma and cosmetic concerns as factors that have limited uptake. A device with no external components removes that visibility entirely.
The 24/7 operation also represents a practical change. Conventional implants must be removed for sleeping and water activities, leaving users without hearing during those periods. Med-El says the TICI Unico works continuously, including underwater, because all components are implanted beneath the skin. The push toward fully implantable designs has intensified across the industry in recent years, with multiple manufacturers exploring concepts that eliminate external parts — making Med-El’s first-to-market commercial launch a competitive milestone.
From Feasibility Studies to Market
The TICI Unico is the result of a multi-year development program that the hearing healthcare industry has followed closely. Med-El reported feasibility study results for its TICI platform before conducting early surgeries in Europe with the technology, according to The Hearing Review. The TICI Unico is the commercial product emerging from that research and clinical work.
Med-El, headquartered in Innsbruck, Austria, has been a cochlear implant pioneer for decades. Co-founder and CEO Ingeborg Hochmair has been central to the company’s implant innovation since its early years. Beyond the TICI Unico launch, the company has recently broadened its portfolio through the Rescue Hearing gene therapy acquisition and the Starkey bimodal Bluetooth collaboration.
“TICI Unico is a new category of an implant. It is totally new and it is the realization of a dream that I have had for a very long time.”
— Ingeborg Hochmair, Med-El co-founder and CEO
What Med-El Has Not Yet Detailed
Several practical details remain unclear from the launch announcement. Med-El has not specified which markets the TICI Unico will be available in first, nor a timeline for broader international rollout. Pricing and insurance coverage have not been disclosed.
Clinical detail is also limited. The company reported “promising” feasibility study results, but full outcome data — including speech perception performance compared with conventional cochlear implants, battery life and charging requirements, and candidate criteria such as degree of hearing loss — has not been published in the launch materials. The claim that it is the world’s “only” totally invisible cochlear implant is the company’s own description; independent verification of the first-to-market status has not been reported.
Rollout, Data, and Eligibility Ahead
Watch for initial clinical results from the first commercial implants, which will indicate how hearing performance compares with conventional external-processor systems. Details on patient eligibility — including degree and type of hearing loss the device is approved for — are expected as the rollout proceeds.
Market availability, regulatory approvals in additional regions, and pricing information are likely to emerge in coming months. Med-El has said additional information about the TICI Unico is available at medel.com. Competitors pursuing fully implantable designs may also respond with their own clinical or commercial updates as the category develops.
Key Questions
What makes the TICI Unico different from a conventional cochlear implant?
Conventional cochlear implants require an external sound processor worn behind the ear or on the head. The TICI Unico is designed to function entirely under the skin, including the microphone, so there are no externally visible components during everyday use.
Can the TICI Unico be used while sleeping or swimming?
Yes, according to Med-El. Because all components are implanted beneath the skin, the company says the device works 24/7, including while sleeping, showering, and swimming, and is not affected by water.
Is the TICI Unico available worldwide?
Med-El has not yet specified which markets the device will launch in first or a timeline for international availability. Early surgeries with the TICI platform were conducted in Europe before the commercial launch.
Who is a candidate for the TICI Unico?
Med-El positions the device for patients who prioritize discretion and convenience alongside hearing performance. Specific eligibility criteria, such as degree and type of hearing loss, have not been detailed in the launch announcement and are expected as the rollout proceeds.
Has the device been tested clinically?
Med-El reported promising feasibility study results for its TICI platform before launching the commercial product, according to The Hearing Review. Full published outcome data, including performance comparisons with conventional implants, is not yet available.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
